Market Research Logo

Global Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players and financials

Global Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players and financials
The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2018: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest monoclonal antibody agreements announced in the healthcare sectors, covering: Monoclonal antibodies
Murine mAb
Chimeric mAb
Humanized mAb
Human aAb
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all monoclonal antibody partnering deals announced since Jan 2010, including financial terms where available, including links to online deal records of actual monoclonal antibody partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. The initial chapters of this report provide an orientation of monoclonal antibody dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in monoclonal antibody dealmaking since 2010, including details of average headline, upfront, milestone and royalty terms. Chapter 3 provides a review of the leading monoclonal antibody deals since 2010. Deals are listed by headline value, signed by big pharma, most active monoclonal antibody dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 25 most active companies in monoclonal antibody dealmaking with a brief summary followed by a comprehensive listing of monoclonal antibody deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand. Chapter 5 provides a comprehensive and detailed review of monoclonal antibody partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Chapter 7 provides a comprehensive and detailed review of monoclonal antibody partnering deals signed and announced since Jan 2010. The chapter is organized by specific monoclonal antibody technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. In addition, a comprehensive appendix is provided organized by monoclonal antibody partnering company A-Z, deal type definitions and monoclonal antibody partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in monoclonal antibody partnering and dealmaking since 2010.In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of monoclonal antibody technologies and products. Key benefits Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2018 provides the reader with the following key benefits: In-depth understanding of monoclonal antibodies deal trends since 2010
Access to headline, upfront, milestone and royalty data
Access to the structure of monoclonal antibodies agreements with numerous real life case studies
Comprehensive access to over 700 actual monoclonal antibodies deals entered into by the world’s biopharma companies
Identify the leading monoclonal antibody partnering companies
Insight into the terms included in a monoclonal antibodies agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Report scope Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2018 is intended to provide the reader with an in- depth understanding and access to monoclonal antibodies trends and structure of deals entered into by leading companies worldwide. Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2018 includes: o Trends in monoclonal antibodies dealmaking in the biopharma industry since 2010o Analysis of monoclonal antibodies deal structureo Access to headline, upfront, milestone and royalty datao Access to over 700 monoclonal antibodies deal recordso The leading monoclonal antibodies deals by value since 2010o Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2010 In Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2018, the available deals are listed by: o Company A-Zo Headline valueo Stage of development at signingo Deal component typeo Monoclonal antibodies type Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The Global Monoclonal Antibody Partnering Terms and Agreements 2010 to 2018 report provides comprehensive access to available deals and contract documents for over 700 monoclonal antibody deals. Analyzing actual contract agreements allows assessment of the following: What are the precise monoclonal antibody rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in monoclonal antibody dealmaking
    • Introduction
    • Monoclonal antibody partnering over the years
    • Most active monoclonal antibody dealmakers
    • Monoclonal antibody partnering by deal type
    • Monoclonal antibody partnering by therapy area
    • Deal terms for monoclonal antibody partnering
      • Monoclonal antibody partnering headline values
        • Table Monoclonal antibody deals with a headline value
      • Monoclonal antibody deal upfront payments
        • Table Monoclonal antibody deals with an upfront value
      • Monoclonal antibody deal milestone payments
        • Table Monoclonal antibody deals with a milestone value
      • Monoclonal antibody royalty rates
        • Table Monoclonal antibody deals with a royalty rate value
  • Leading monoclonal antibody deals
    • Introduction
    • Top monoclonal antibody deals by value
      • Table Top monoclonal antibody deals by value since 2012
  • Most active monoclonal antibody dealmakers
    • Introduction
    • Most active monoclonal antibody dealmakers
    • Most active monoclonal antibody partnering company profiles
      • Merck and Co
      • Pfizer
      • Bristol-Myers Squibb
      • MedImmune
      • Genentech
      • Amgen
      • GlaxoSmithKline
      • Lonza
      • Open Monoclonal Technology
      • Adimab
      • Janssen Biotech
      • AstraZeneca
      • National Cancer Institute
      • Nexvet
      • Novartis
      • Merck KGaA
      • Roche
      • Sanofi
      • Boehringer Ingelheim
      • Eli Lilly
      • Regeneron Pharmaceuticals
      • Sorrento Therapeutics
      • Trianni
      • Abbvie
      • Celgene
  • Monoclonal antibody contracts dealmaking directory
    • Introduction
    • Monoclonal antibody contracts dealmaking directory
  • Monoclonal antibody dealmaking by technology type
    • Monoclonal antibodies
    • Chimeric mAb
    • Humanized mAb
    • Human mAb
    • Murine mAb
  • Partnering resource center
    • Online partnering
    • Partnering events
    • Further reading on dealmaking
  • Appendices
    • Monoclonal antibody deals by company A-Z
      • 3SBio
      • 4-Antibody
      • 4D Pharma
      • Abbott Laboratories
      • Abbvie
      • Abcam
      • AbCellera
      • AbCheck
      • AbD Serotec
      • Abeome
      • Ablexis
      • Ablynx
      • Abpro
      • Abzena
      • Acceleron Pharma
      • Achaogen
      • Acticor Biotech
      • Actinium Pharmaceuticals
      • Adaptimmune
      • Adaptive Biotechnologies
      • ADC Therapeutics
      • Adimab
      • ADMA Biologics
      • Aduro BioTech
      • Advanced BioScience Laboratories
      • Advantagene
      • Advaxis
      • Aeglea BioTherapeutics
      • AET Biotech
      • Aevi Genomic Medicine
      • Affimed Therapeutics
      • Affinita Biotech
      • Affitech
      • AGC Biologics
      • Agenus Bio
      • Agilvax
      • Aimmune Therapeutics
      • AIMM Therapeutics
      • Alder Biopharmaceuticals
      • Alector
      • Alethia Biotherapeutics
      • Alexion Pharmaceuticals
      • Algeta
      • Allergan
      • Alligator Bioscience
      • Almirall
      • Althea Technologies
      • Alvogen
      • Ambrx
      • American College of Cardiology
      • Amgen-Beta Pharmaceuticals
      • Amgen
      • Amgen Astellas BioPharma
      • Amneal Pharmaceuticals
      • AnaptysBio
      • AnGes MG
      • Angiogene
      • Annexon
      • Anthera Pharmaceuticals
      • Antigen Express
      • Antitope
      • Apceth
      • Apeiron Biologics
      • Aperion Biologics
      • Apexigen
      • APO-T
      • Areva Med
      • ArGEN-X
      • Aridis Pharmaceuticals
      • ARMO Biosciences
      • Array Biopharma
      • Arrowhead Pharmaceuticals
      • Arsanis Biosciences
      • Ascenion
      • Aslan Pharma
      • Astellas Pharma
      • Astex Pharmaceuticals
      • AstraZeneca
      • Atara Biotherapeutics
      • Athenex
      • Athera Biotechnologies
      • Atlab Pharma
      • Australian Research Council
      • Auven Therapeutics
      • AvantGen
      • AVEO Oncology
      • Avid Bioservices
      • Aytu BioScience
      • Back-A-Line
      • Banook Central Imaging
      • Bavarian Nordic
      • Baxalta
      • Bayer
      • Bayer Healthcare
      • Baylor Institute for Immunology Research
      • BB100
      • BeiGene
      • Ben-Gurion University
      • BerGenBio
      • Berkeley Lights
      • Biametrics
      • Bill and Melinda Gates Foundation
      • BioAtla
      • Biocare Medical
      • Bioceros
      • BiocerOX Products
      • Biocnd
      • Biodesix
      • BioDuro
      • Biofactura
      • Biogen
      • BioInvent
      • Biolex
      • BiolineRX
      • Biologics
      • BioMarker Strategies
      • Biomedical Advanced Research and Development Authority
      • BioRap Technologies
      • Biotest
      • Biothera
      • BioWa
      • BioXpress
      • Bio Farma
      • BliNK Biomedical
      • BliNK Therapeutics
      • Boehringer Ingelheim
      • Boston University
      • Brigham and Women's Hospital
      • Bristol-Myers Squibb
      • C2N Diagnostics
      • Caliber Biotherapeutics
      • California Institute for Regenerative Medicine
      • Calithera Biosciences
      • Calypso Biotech
      • Cambridge Research Biochemicals
      • Cancer Prevention and Research Institute of Texas
      • Cancer Research Institute
      • Cancer Research Technology
      • Cancer Research UK
      • Catalent Pharma Solutions
      • CBT Pharmaceuticals
      • CDI Laboratories
      • Cedars-Sinai Medical Center
      • Celexion
      • Celgene
      • Celimmune
      • Celldex Therapeutics
      • Cellectis
      • Cellmid
      • Celltrion
      • Cell Marque
      • Cell Signaling Technology
      • Center for iPS Cells Research and Application
      • Centre for Drug Research and Development (CDRD)
      • ChemomAb
      • Chinese Academy of Sciences
      • Chiome Bioscience
      • Chugai Pharmaceutical
      • Cimym
      • City of Hope
      • City University of New York Center for Advanced Technology
      • CJSC Biocad
      • Clal Biotech
      • Clinica Universidad Navarra
      • Clovis Oncology
      • CMC Biologics
      • CNA Development
      • Cobra Biologics
      • Coherus Biosciences
      • Complement Pharma
      • Conkwest
      • ContraFect
      • Cook Pharmica
      • Cormorant Pharmaceuticals
      • Corvidia Therapeutics
      • Corvus Pharmaceuticals
      • Cosmo Pharmaceuticals
      • CoStim Pharmaceuticals
      • Covagen
      • Covalab
      • Creative Biolabs
      • Creative Diagnostics
      • Crescendo Biologics
      • Crown Bioscience
      • Crystal Bioscience
      • CR Pharma
      • CSL
      • CSPC Pharmaceutical Group
      • Cullinan Oncology
      • Curant Health
      • CureTech
      • Curie-Cancer
      • Cytodyn
      • CytomX Therapeutics
      • Cytovance Biologics
      • Daiichi Sankyo
      • Dako
      • Debiopharm
      • DecImmune Therapeutics
      • Defense Advanced Research Projects Agency
      • Defyrus
      • Denali Therapeutics
      • DendroCyte
      • Department of Defense
      • Department of Health and Human Services
      • Dermira
      • DiaSorin
      • Distributed Bio
      • DNAtrix
      • Dr. Jeffrey Jacobson
      • Dr. Reddy's Laboratories
      • Drexel University
      • DRI Capital
      • DSM
      • DSM Pharmaceutical Products
      • Dyadic International
      • Dyax
      • Dynavax Technologies
      • EA Pharma
      • Eclipse Aesthetics
      • Eddingpharm
      • EFFECTOR Therapeutics
      • Effimune
      • EirGenix
      • Eisai
      • Eleven Biotherapeutics
      • Eli Lilly
      • ElsaLys Biotech
      • EluSys Therapeutics
      • EMD Millipore
      • EMD Serono
      • Emergent BioSolutions
      • Enthera
      • Enumeral Biomedical
      • Enzo Biochem
      • Epicypher
      • Epirus Biopharmaceuticals
      • EpiThany
      • Epitomics
      • Epivax
      • Erasmus University Medical Center
      • Essex Bio-Technology
      • Eureka Therapeutic
      • Eurofarma
      • European Commission
      • European Union
      • EUSA Pharma
      • Eutilex
      • Evotec
      • Expression Analysis
      • Faron Pharmaceuticals
      • Fate Therapeutics
      • Ferring Pharmaceuticals
      • Five Prime Therapeutics
      • Food and Drug Administration (FDA)
      • Formosa Laboratories
      • Forty Seven
      • Fountain BioPharma
      • Fred Hutchinson Cancer Research Center
      • Fujifilm Diosynth Biotechnologies
      • Fujifilm Kyowa Kirin Biologics
      • Fundacio Clinic
      • Galapagos
      • Galderma
      • Galena Biopharma
      • Gallus Biopharmaceuticals
      • GamaMabs Pharma
      • GBS-CIDP Foundation
      • GC Pharma
      • Genentech
      • GeNeuro
      • Geneva Foundation
      • Genexine
      • Genmab
      • Genome Institute of Singapore
      • Genomic Health
      • Genor Biopharma
      • Gen Ilac
      • Georgetown University
      • German Ministry for Education and Research
      • Gilead Sciences
      • Gladstone Institutes
      • GlaxoSmithKline
      • Glenmark Pharmaceuticals
      • Global Blood Therapeutics
      • Glycocept
      • Glycotope Biotechnology
      • Glythera
      • Goodwin Biotechnology
      • Gradalis
      • Gritstone Oncology
      • GTP Technology
      • H-Immune
      • Hadasit Bioholdings
      • Halozyme Therapeutics
      • HanAll Pharmaceuticals
      • Harbour Antibodies
      • Harbour Biomed
      • Harvard Pilgrim Health Care
      • Heidelberg Pharma
      • Heptares Therapeutics
      • HiFiBio
      • Hikma Pharmaceuticals
      • Hoffmann La Roche
      • Horizon Discovery
      • Hospira
      • Hubrecht Institute
      • Humabs BioMed
      • Humanigen
      • Human BioMolecular Research Institute
      • Hummingbird Bioscience
      • I2 Pharmaceuticals
      • IBA Molecular Imaging
      • IBC Generium
      • IBio
      • Icahn School of Medicine at Mount Sinai
      • IDD Biotech
      • Idera Pharmaceuticals
      • IDIS Pharma
      • Ildong Pharmaceutical
      • Illumina
      • Imab
      • ImaginAb
      • ImmuneXcite
      • ImmuNext
      • Immune Design
      • Immune Pharmaceuticals
      • ImmunGene
      • ImmunoChina Pharmaceuticals
      • Immunocore
      • ImmunoGen
      • Immunomedics
      • Immunomic
      • Immutep
      • Incyte
      • InDevR
      • Index Ventures
      • Infinity Pharmaceuticals
      • Innate Pharma
      • InnoKeys
      • InnoMab
      • Innovate UK
      • Innova Biosciences
      • Innovent Biologics
      • INovacia
      • Inovio Pharmaceuticals
      • Inserm
      • Inserm Transfert
      • Institute of Biophysics
      • Institut Curie
      • Institut Gustave Roussy
      • Institut Pasteur
      • Intarcia Therapeutics
      • Integral Molecular
      • Intellect Neurosciences
      • International Consortium on Anti-Virals
      • Intrexon
      • Invenra
      • IONTAS
      • IO Biotech
      • Ipca Laboratories
      • ISA Pharmaceuticals
      • IsoTherapeutics
      • Israeli National Authority for Technological Innovation
      • Israel Institute for Biological Research
      • ITeos Therapeutics
      • Izana Bioscience
      • Janssen Alzheimer Immunotherapy
      • Janssen Biotech
      • Janssen Pharmaceuticals
      • Janssen Research & Development
      • Janssen Sciences
      • Jazz Pharmaceuticals
      • JHL Biotech
      • Jiangsu Hengrui Medicine
      • Johnson & Johnson
      • Johnson & Johnson Innovation
      • Johns Hopkins Medicine (JHM)
      • Johns Hopkins University
      • John Hopkins University School of Medicines
      • Jounce Therapeutics
      • Juno Therapeutics
      • Kadmon Pharmaceuticals
      • Karolinska Development
      • Kelun-Biotech Biopharmaceutical
      • Kemwell BioPharma
      • Kenta Biotech
      • KineMed
      • Kite Pharma
      • Kocak Pharma
      • Kodiak Sciences
      • Kolltan Pharmaceuticals
      • Kymab
      • Kyoto University
      • Kyowa Hakko Kirin
      • Lab21
      • Laboratoires Thea
      • Laboratorios Liomont
      • Labrys Biologics
      • LakePharma
      • Lankenau Institute for Medical Research
      • LA Cell
      • Leaf Biopharmaceutical
      • Leap Therapeutics
      • Lee's Pharmaceutical
      • Leica Biosystems
      • Leica Microsystems
      • LEO Pharma
      • Leukemia & Lymphoma Society
      • LFB Biotechnologies
      • LG Life Sciences
      • Libbs Farmaceutica
      • LifeArc
      • Life Technologies Corporation
      • Ligacept
      • Ligand Pharmaceuticals
      • LinXis
      • Livzon Mabpharm
      • Lonza
      • Lpath
      • Ludwig Institute for Cancer Research
      • Lupagen
      • Lupin
      • MabCure
      • Mabion
      • MabQuest
      • Mabspace Bioscience
      • MabVax Therapeutics
      • MAbXience
      • MAB Discovery
      • Macquarie University
      • Macrogenics
      • Magenta Therapeutics
      • Mapp Biopharmaceutical
      • Maryland Technology Development Corporation
      • Massachusetts General Hospital
      • Massachusetts Institute of Technology
      • Mayo Clinic
      • MD Anderson Cancer Center
      • Medgenics
      • Medicago
      • Medical Research Council
      • Medigen Biotechnology
      • MedImmune
      • Mediolanum
      • Mediomics
      • Medison Pharma
      • Medistem
      • Medivation
      • Medtronic
      • Melanoma Research Foundation
      • Memorial Sloan Kettering Cancer Center
      • Merck and Co
      • Merck KGaA
      • Merck Serono
      • Merck Sharpe & Dohme
      • Merrimack Pharmaceuticals
      • Mersana Therapeutics
      • Merus
      • Mesoblast
      • MicroConstants
      • Micromet
      • MiniVax
      • Minomic
      • Miraculins
      • Mitsubishi Tanabe Pharma
      • ModiQuest Research
      • Momenta Pharmaceuticals
      • MorphoSys
      • Morphotek
      • Mount Sinai Medical Center
      • Mylan Laboratories
      • Mylan Pharmaceuticals
      • Myriad Genetics
      • NantBioScience
      • NantCell
      • NantKwest
      • Nantong Jinghua Pharmaceutical
      • NantWorks
      • Nanyang Technological University
      • Nascent Biotech
      • National Cancer Institute
      • National Center for Advancing Translational Sciences (NCATS)
      • National Center for Tumor Diseases
      • National Comprehensive Cancer Network (NCCN)
      • National Heart, Lung and Blood Institute
      • National Institutes of Health
      • National Institute for Viral Sidease Control and Prevention
      • National Institute of Allergy and Infectious Diseases
      • National Institute of Standards and Technology
      • Navidea Biopharmaceuticals
      • NCIC Clinical Trials Group
      • Nektar Therapeutics
      • NeoBiotechnologies
      • NeoImmuneTech
      • Neon Therapeutics
      • NeuClone
      • Neurimmune Therapeutics
      • Neuroblastoma and Medulloblastoma Translational Research
      • Newlink Genetics
      • Newsummit Biopharma
      • Nexvet
      • Nordic Bioscience
      • Northern Biologics
      • Northwestern University
      • NovaRock Biotherapeutics
      • Novartis
      • Novasep
      • Novelogics Biotechnology
      • NovImmune
      • Novo Nordisk
      • Noxxon Pharma
      • Numab
      • Numerate
      • OcellO
      • Ohio Clinical Trials Collaborative
      • Ology Bioservices
      • Olympic Protein Technologies
      • Oncobiologics
      • OncoImmune
      • Oncologie
      • OncoMax
      • OncoMed Pharmaceuticals
      • OncoQuest
      • OncoSec Medical
      • Oncosynergy
      • Oncothyreon
      • Oncternal Therapeutics
      • Oncurious
      • Ono Pharmaceutical
      • Open Monoclonal Technology
      • OPKO Health
      • Opthea
      • Organic Vaccines
      • OSE Immunotherapeutics
      • Otsuka
      • Oxford BioTherapeutics
      • OXiGENE
      • PacificGMP
      • Pall Corporation
      • Pamlico Biopharma
      • Panacea Pharmaceuticals
      • Pandion Therapeutics
      • PATH Malaria Vaccine Initiative
      • Patrys
      • PDS Biotechnology
      • Pelican Therapeutics
      • Percivia
      • Peregrine Pharmaceuticals
      • Perelman School of Medicine
      • Pfenex
      • Pfizer
      • PharmAbcine
      • Pharmacyclics
      • Pharmanet/i3
      • PharmaPraxis
      • PharmAthene
      • Philogen
      • Pierre Fabre
      • PlantForm
      • Polpharma
      • Portal Instruments
      • Poseida Therapeutics
      • Potenza Therapeutics
      • Precision Biologics
      • Prestige Brands
      • Probiodrug AG
      • ProBioGen
      • Progenics Pharmaceuticals
      • Prothena Biosciences
      • Prothix
      • ProtoKinetix
      • Provention Bio
      • Provista Diagnostics
      • PULSALYS
      • Purolite
      • Quantum Leap Health Care Collaborative
      • Queensland Institute of Medical Research (QIMR)
      • Q Therapeutics
      • R-Pharm
      • RayBiotech
      • Recepta Biopharma
      • Receptos
      • Regeneron Pharmaceuticals
      • Rentschler Biotechnologie
      • Repligen
      • Rezolute
      • River Vision Development
      • Roche
      • Rockefeller University
      • Rockland Immunochemicals
      • Roivant Sciences
      • RuiYi
      • Saber Bioscience
      • SAB Therapeutics
      • Salk Institute
      • Samsung Bioepis
      • Samsung Biologics
      • Sanford Burnham Institute
      • Sanofi-Aventis
      • Sanofi-Pasteur
      • Sanofi
      • Sanofi Aventis Korea
      • Sanofi Pasteur KK
      • Sanquin Blood Supply Foundation
      • Sarah Cannon Research Institute
      • SATT Sud-Est
      • Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
      • Schrodinger
      • Scripps Research Institute
      • Seattle Genetics
      • Sea Lane Biotechnologies
      • SEEK
      • Selexis
      • Selexys Pharmaceuticals
      • SELLAS Life Sciences Group
      • Serum Institute of India
      • Servier
      • Sevion Therapeutics
      • ShanghaiTech University
      • Shanghai Duyiwei Biotech
      • ShangPharma
      • Shenzhen Arimab Biopharmaceuticals
      • Shenzhen Hepalink Pharmaceutical
      • Shire Pharmaceuticals
      • Sialix
      • Single Cell Technology
      • Small Business Innovation Research
      • Solentim
      • Soligenix
      • Sorrento Therapeutics
      • Spectrum Pharmaceuticals
      • Spirogen
      • Stanford University
      • STC Biologics
      • Stem Cell Therapeutics
      • Strox Biopharmaceuticals
      • Structural Genomics
      • Structural Genomics Consortium
      • Sun Pharmaceutical
      • Superview Biotechnology
      • SuppreMol
      • Surface Oncology
      • Swedish Orphan
      • Swedish Orphan Biovitrum
      • Symphogen
      • Syndax Pharmaceuticals
      • Synthetic Biologics
      • Synthon
      • Syros Pharmaceuticals
      • TaiMed
      • Taiwan Ministry of Economic Affairs
      • Takeda Pharmaceutical
      • Tanabe Research Laboratories
      • TARIS Biomedical
      • Tasly Pharmaceuticals
      • Technology Strategy Board (UK)
      • Telix Pharmaceuticals
      • TeneoBio
      • Tesaro
      • Tetragenetics
      • TetraLogic Pharmaceuticals
      • Teva Pharmaceutical Industries
      • TG Therapeutics
      • Theradiag
      • Theranyx
      • Theravectys
      • The Hospital for Sick Children
      • ThromboGenics
      • Tikcro Technologies
      • Tiziana Life Sciences
      • TOT BIOPHARM
      • TRACON Pharmaceuticals
      • TransBio
      • Transgene
      • Transgene Tasly Biopharmaceutical
      • Translational Sciences
      • Transporin
      • Trellis Bioscience
      • Tri-Institutional Therapeutics Discovery Institute
      • Trianni
      • Trieza Therapeutics
      • UCB
      • Ultragenyx Pharmaceuticals
      • UMass Memorial Medical Center
      • Unilife
      • Universite Claude Bernard Lyon
      • University College London
      • University Health Network
      • University Medical Center Utrecht
      • University of Alabama at Birmingham
      • University of British Columbia
      • University of California, Davis
      • University of California, San Diego
      • University of California Irvine
      • University of California Los Angeles
      • University of California San Francisco
      • University of Chicago
      • University of Cologne
      • University of Illinois at Chicago
      • University of Maryland Baltimore
      • University of Massachusetts Medical School
      • University of Minnesota
      • University of Nottingham
      • University of Pennsylvania
      • University of Rochester
      • University of Texas
      • University of Toronto
      • University of Wisconsin Carbone Cancer Center (UWCCC)
      • Unum Therapeutics
      • US Government
      • Utrecht University
      • Vaccinex
      • Valeant Pharmaceuticals
      • Valneva
      • Valor Biotherapeutics
      • Vascular Pharmaceuticals
      • Vaximm
      • Ventana Medical Systems
      • Verastem
      • VIB
      • Vical
      • Viela Bio
      • Viralytics
      • Virbac
      • Viropro
      • Vir Biotechnology
      • Visterra
      • Vitaeris
      • VivaMab
      • VLST Corporation
      • Voyager Therapeutics
      • Vyriad
      • Washington University in St Louis
      • Watson Pharmaceuticals
      • Weizmann Institute
      • Wellcome Trust Sanger Institute
      • Wilex
      • Wistar Institute
      • World Health Organization
      • Wuxi Apptec Laboratory Services
      • WuXi Biologics
      • WuXi PharmaTech
      • XBiotech
      • Xbrane Bioscience
      • XCella Biosciences
      • Xencor
      • Xiamen University
      • XO1
      • Xoma
      • Yale University
      • Yeda Research and Development Company
      • Yissum Research Development
      • YL Biologics
      • Yoshindo
      • ZAI Laboratory
      • Zenoaq
      • Zenyaku Kogyo
      • Zhejiang Beta Pharma
      • Zhejiang Hisun Pharmaceutical
      • Zhejiang Huahai Pharmaceutical
      • Zoetis
      • Zymeworks
    • Monoclonal antibody deals by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Monoclonal antibody deals by deal type
      • Asset purchase
      • Assignment
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Co-promotion
      • CRADA
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Marketing
      • Material transfer
      • Option
      • Promotion
      • Research
      • Settlement
      • Spin out
      • Sub-license
      • Supply
      • Technology transfer
      • Termination
    • Monoclonal antibody deals by therapy area
      • Cardiovascular
      • Long QT syndrome
      • Atherosclerosis
      • Cardiomyopathy (heart muscle disease)
      • Congestive heart failure
      • Coronary artery disease
      • Hypercholesterolemia
      • Ischemic heart disease
      • Myocardial Infarction
      • Thrombus (blood clot)
      • Central Nervous System
      • Cerebral palsy
      • Creutzfeldt Jakob disease
      • Viral
      • Migraine
      • Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease)
      • Multiple sclerosis
      • Neuropathy
      • Pain
      • Parkinson's disease
      • Spinal cord
      • Stroke
      • Dental
      • Dermatology
      • Dermatitis
      • Psoriasis
      • Gastrointestinal
      • Celiac disease
      • Esophagitis
      • Inflammatory bowel disease
      • Crohn's disease
      • Ulcerative colitis
      • Sickle cell disease
      • Nephrotic syndrome
      • Human papillomavirus (HPV)
      • Menopause
      • Hematology
      • Disseminated intravascular coagulation (DIC)
      • Hemophilia
      • Immune thrombocytopenic purpura
      • Orthopedics
      • Transplantation
      • Immunology
      • AIDS
      • Allergy
      • Other autoimmune
      • Graft versus host disease
      • Inflammation
      • Systemic lupus erythematosus
      • Infectives
      • Bacterial
      • Anthrax
      • Escherichia Coli (E-coli)
      • Methicillin-resistant Staphylococcus aureus (MRSA)
      • Pertussis (Whooping Cough)
      • Pseudomonas aeruginosa
      • Sepsis
      • Fungal
      • Dengue fever
      • Malaria
      • Viral
      • Ebola
      • HIV
      • Influenza
      • Respiratory syncytial virus (RSV)
      • Zika
      • Metabolic
      • Diabetes
      • Type 1
      • Type 2
      • Liver disease
      • Nonalcoholic steatohepatitis (NASH)
      • Musculoskeletal
      • Arthritis
      • Ankylosing spondylitis
      • Juvenile arthritis
      • Osteoarthritis
      • Psoriatic arthritis
      • Rheumatoid arthritis
      • Bone fracture
      • Back pain
      • Bone pain
      • Osteoporosis
      • Pre-eclampsia
      • Oncology
      • Adenocarcinoma
      • Bladder cancer
      • Bone cancer
      • Brain cancer
      • Breast cancer
      • Cervical cancer
      • Colorectal cancer
      • Endometrial
      • Esophageal cancer
      • Gastric cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Acute lymphoblastic leukemia
      • Acute myelogenous leukemia
      • Chronic lymphocytic leukemia
      • Chronic myelogenous leukemia
      • Liver cancer
      • Lung cancer
      • Non small cell lung cancer
      • Small cell lung cancer
      • Lymphoma
      • Hodgkin's lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Metastases
      • Multiple myeloma
      • Neuroblastoma
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Renal cell carcinoma
      • Sarcoma
      • Solid tumors
      • Cachexia
      • Cancer pain
      • Thyroid cancer
      • Ophthalmics
      • Age-related macular degeneration
      • Diabetic macular edema
      • Dry eye
      • Retinopathy
      • Uveitis
      • Orphan disease
      • Pediatrics
      • Psychiatry
      • Alzheimers
      • Autism
      • Schizophrenia
      • Insomnia
      • Obesity
      • Respiratory
      • Asthma
      • Chronic obstructive pulmonary disease
      • Idiopathic pulmonary fibrosis
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report